Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Arch Womens Ment Health. 2013 Oct 3;17(1):17–26. doi: 10.1007/s00737-013-0383-6

Figure 2.

Figure 2

Figure 2

Figure 2A. Results of the interrupted time-series analysis focused on the association between release of the FDA and Health Canada pregnancy warnings and antidepressant prescribing during pregnancy, using a 4 month transition period (June 1, 2004–September 30, 2004).

Figure 2B. Results of the interrupted time-series analysis that estimated the association between pregnancy and suicide warnings and antidepressant prescribing during pregnancy, using an expanded transition period (January 1, 2004–October 31, 2004).